Half of the top stocks in the market cap… Increased benefits in the aftermath of Corona 19 and Donghak ants
[팍스넷뉴스 김민아 기자] KOSDAQ, which had been sluggish at the beginning of this year, has 1,000 points in the tardy fluctuation index of top stocks by market capitalization. Pharmaceutical and bio-related stocks, which had been sluggish last year, revived, and stocks with high growth potential, such as electric vehicles and Untact, took the lead.
According to the Korea Exchange on the 31st, the total market capitalization of the KOSDAQ market this year was 385 trillion won. It increased by 59.8% compared to the end of the previous year (24.04 trillion won). The average daily transaction value was 1,081 trillion won, up 150.9% from the end of the previous year (4.1 trillion won). The transaction volume also increased 97.8% from 825 million shares to 1,631 billion shares.
Top companies in the market capitalization have also been replaced. As of the end of this year, Celltrion Healthcare, the No. 1 company in the KOSDAQ market cap, was counted at 24.700 trillion won. Following that, Celltrion Pharmaceutical (8.5 trillion won), Seegene (5.1 trillion won), Alteogen (5 trillion won), HLB (4.900 trillion won), SK Materials (3.8 trillion won), Ecopro BM ( 3.6 trillion won), Kakao Games (3.4 trillion won), Pearl Abyss (3.4 trillion won), and KM Double U (3.2 trillion won).
It is also the pharmaceutical and bio industries that have driven the cataclysmic shift. This year’s market cap from 1st to 5th was occupied by pharmaceutical and biotech companies. Celltrion Pharmaceutical (20th), Seegene (43th), and Alteogen (32th) were all out of the top 10, except for Celltrion Healthcare and HLB, which ranked first and second at the end of last year, but ranked 5th within a year. Jumped up.
Celltrion Pharmaceutical and Seegene each increased their market cap by 530% compared to the end of the previous year, showing the highest growth rate. Alteogen rose by 443%, followed by Ecopro BM (228%) and Celltrion Healthcare (224%).
The pharmaceutical and bio stocks showed weakness due to a series of clinical-related adverse events such as the Kolon TissueGene Invossa incident last year, the failure to reach the clinical targets of HLB, and the recommendation to discontinue the Sillagen clinical trial.
Among the top 10 companies in the market cap last year, only three pharmaceutical and bio companies were Celltrion Healthcare (1st), HLB (2nd), and Helixmith (7th). The vacancy of the bio company was occupied by the general manager (materials, parts, equipment). This is because the government declared its fostering in the aftermath of the trade conflict between Korea and Japan at the time.
Communication equipment company KMDU climbed 90 places to take 6th place, while semiconductor-related companies SK Materials and Wonik IPS jumped from 15th to 8th and 36th to 10th, respectively. In addition to this, entertainment stocks such as CJ ENM (3rd place, 3.5 trillion won) and Studio Dragon (5th place, 2.3 trillion won) were also ranked at the top of the market cap. However, amid the shifting positions of top companies, pharmaceutical and bio stocks have once again regained their leadership positions in the KOSDAQ.
Untact and EV-related stocks also showed strong strength. Ecopro BM, which was ranked 24th last year, rose to 7th, and Kakao Games, which was listed in September, took 8th place. This is because the untekt market has grown rapidly amid the corona 19 pandemic, and the benefits of sustainable growth are predicted in the wake of the expansion of global companies’ entry into the electric vehicle market.
An official from the Korea Exchange said, “This year, the share of the KOSDAQ market capitalization of the pharmaceutical and bio industry increased from 28.1% to 35% due to the active purchase of individual investors for related beneficiaries such as Corona 19 diagnostic kits,” he said.
ⒸLook at the market with new eyes. Unauthorized distribution of Paxnet News is prohibited